Differential responses of mitotic spindle pole formation to microtubule-stabilizing agents epothilones A and B at low concentrations

We previously reported that the microtubule-stabilizing agent docetaxel induced formation of fragile acentrosomal spindle poles but that structurally related paclitaxel did not. In the present study, we examined whether the microtubule-stabilizing agents epothilones A and B, which are structurally similar, affect the centrosome/spindle pole architecture. We investigated mitotic processes in epothilone A or B-treated human MDA-MB-435 cells, in which the centrosomes, spindle poles and mitotic microtubules were simultaneously visualized by GFP-Aurora A kinase. Fluorescence microscopy of metaphase cells indicated that several chromosomes were misaligned away from the metaphase plate when treated with IC50 concentrations of epothilone A or B (4.5 or 2 nM, respectively), suggesting that microtubule dynamics was impaired. Interestingly, epothilone B induced formation of acentrosomal spindle poles, but this effect was not observed for epothilone A. Live-cell imaging showed that aster-like structures ectopically arose around the nuclear envelope at the onset of mitosis in epothilone B-treated cells and that one of these asters became an acentrosomal spindle pole. Aster-like structures also arose in the presence of epothilone A, but they were merged into centrosome-derived spindle poles during prometaphase and completely disappeared until metaphase. These results indicate that the centrosome/spindle pole integrity is strongly affected by epothilone B but is not greatly affected by epothilone A. Our findings show that the two epothilones cause different cellular responses at equipotent concentrations and suggest that they have different mechanisms of activity in cells.

[1]  T. Matsui,et al.  Immunofluorescence detection of ezrin/radixin/moesin (ERM) proteins with their carboxyl-terminal threonine phosphorylated in cultured cells and tissues. , 1999, Journal of cell science.

[2]  G. Moreno-Bueno,et al.  Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis , 2007, Oncogene.

[3]  Live imaging of spindle pole disorganization in docetaxel-treated multicolor cells. , 2007, Biochemical and biophysical research communications.

[4]  P Wadsworth,et al.  Taxol suppresses dynamics of individual microtubules in living human tumor cells. , 1999, Molecular biology of the cell.

[5]  S. Horwitz,et al.  Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. , 2002, Cancer research.

[6]  M. Cammer,et al.  Gene expression and mitotic exit induced by microtubule-stabilizing drugs. , 2003, Cancer research.

[7]  I. Barasoain,et al.  Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. , 2003, Current cancer drug targets.

[8]  Y. Ono,et al.  Characterization of a Novel Giant Scaffolding Protein, CG-NAP, That Anchors Multiple Signaling Enzymes to Centrosome and the Golgi Apparatus* , 1999, The Journal of Biological Chemistry.

[9]  P. Schiff,et al.  Taxol stabilizes microtubules in mouse fibroblast cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Ritzén,et al.  Recent developments in the chemistry, biology and medicine of the epothilones. , 2001, Chemical communications.

[11]  K. Altmann,et al.  Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity. , 2000, Biochimica et biophysica acta.

[12]  M. Bornens,et al.  Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis. , 1997, Journal of cell science.

[13]  K. Sugimoto,et al.  Molecular dynamics of Aurora-A kinase in living mitotic cells simultaneously visualized with histone H3 and nuclear membrane protein importinalpha. , 2002, Cell structure and function.

[14]  P. Giannakakou,et al.  Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)* , 1997, The Journal of Biological Chemistry.

[15]  Alexey Khodjakov,et al.  Kinetochore-driven formation of kinetochore fibers contributes to spindle assembly during animal mitosis , 2004, The Journal of cell biology.

[16]  P. Wender,et al.  Microtubule-stabilizing agents based on designed laulimalide analogues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Ben Cornett,et al.  The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography , 2004, Science.

[18]  K. Altmann,et al.  The biology and medicinal chemistry of epothilones. , 2012, Current medicinal chemistry. Anti-cancer agents.

[19]  J. Baselga,et al.  Targeting the microtubules in breast cancer beyond taxanes: the epothilones. , 2007, The oncologist.

[20]  S. Doxsey,et al.  Re-evaluating centrosome function , 2001, Nature Reviews Molecular Cell Biology.

[21]  E. Lazarides,et al.  Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.

[22]  W. B. Derry,et al.  Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.

[23]  Claudia J. Bode,et al.  Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilization of yeast microtubules. , 2002, Biochemistry.

[24]  U. Klar,et al.  Subcellular distribution of epothilones in human tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Schiff,et al.  Promotion of microtubule assembly in vitro by taxol , 1979, Nature.

[26]  Gema Moreno-Bueno,et al.  Telling Cells How to Die: Docetaxel Therapy in Cancer Cell Lines , 2007, Cell cycle.

[27]  M. Jordan,et al.  Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Heinz,et al.  Much anticipated--the bioactive conformation of epothilone and its binding to tubulin. , 2005, Angewandte Chemie.

[29]  M. Hussain,et al.  Epothilones and the next generation of phase III trials for prostate cancer , 2005, BJU international.